` Comparison: MESO vs ABBV - Alpha Spread

MESO
vs
ABBV

Over the past 12 months, MESO has underperformed ABBV, delivering a return of +4% compared to the ABBV's +12% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
MESO
ABBV
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

MESO Intrinsic Value
16.22 USD
Overvaluation 4%
Intrinsic Value
Price
ABBV Intrinsic Value
219.81 USD
Overvaluation 4%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Mesoblast Ltd
NASDAQ:MESO
16.88 USD
Abbvie Inc
NYSE:ABBV
228.37 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
MESO, ABBV

MESO
ABBV
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Mesoblast Ltd
Revenue
Abbvie Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
MESO, ABBV

MESO
ABBV
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Mesoblast Ltd
NASDAQ:MESO
Abbvie Inc
NYSE:ABBV
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

MESO
70.2%
ABBV
71.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Abbvie Inc

Operating Margin

MESO
-478.5%
ABBV
33.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Abbvie Inc

Net Margin

MESO
-593.9%
ABBV
3.9%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Abbvie Inc

FCF Margin

MESO
-294.4%
ABBV
33%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Abbvie Inc

ROE

MESO
-19%
ABBV
138.5%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Abbvie Inc

ROA

MESO
-14.1%
ABBV
1.7%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Abbvie Inc

ROIC

MESO
-13.7%
ABBV
28.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Abbvie Inc

ROCE

MESO
-12.9%
ABBV
20.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Mesoblast Ltd
Abbvie Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
MESO, ABBV

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
MESO, ABBV

Loading
MESO
ABBV
Difference
www.alphaspread.com

Performance By Year
MESO, ABBV

Loading
MESO
ABBV
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare MESO to other stocks
PNEXF
Pharnext SCA
ATXS
Astria Therapeutics Inc
AMGN
Amgen Inc
GILD
Gilead Sciences Inc
Custom
Choose any stock
Unlock Full Access to Alpha Spread
Create Free Account